Global Capsule Endoscopy Market Size is valued at USD 557.1 Million in 2024 and is predicted to reach USD 1330.9 Million by the year 2034 at a 9.2% CAGR during the forecast period for 2025-2034. Capsule endoscopy makes use of a tiny wireless camer...
Report ID: 1086 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Global Alternative Proteins Market Size is valued at USD 16.9 Bn in 2024 and is predicted to reach USD 53.2 Bn by the year 2034 at a 12.2 % CAGR during the forecast period for 2025-2034. The Alternative proteins are food-technology or plant-based al...
Report ID: 1085 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Allogeneic Cell Therapy Market Size is valued at 997.36 Million in 2022 and is predicted to reach 2853.34 Million by the year 2031 at a 12.7 % CAGR during the forecast period for 2023 to 2031. Allogeneic Cell Therapy Market Size, Share & ...
Report ID: 1084 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
Global Immuno-Oncology Cell Therapy Market Size is valued at USD 11.9 Billion in 2024 and is predicted to reach USD 95.3 Billion by the year 2034 at a 23.2% CAGR during the forecast period for 2025-2034. Immuno-oncology cell therapies are a remark...
Report ID: 1083 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Global AI-Based Clinical Trial Solution Providers Market Size is valued at USD 2.3 Billion in 2024 and is predicted to reach USD 16.6 Billion by the year 2034 at a 22.0% CAGR during the forecast period for 2025-2034. Artificial Intelligence is a s...
Report ID: 1082 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Rituximab Biosimilar Market is expected to grow at a 12.3% CAGR during the forecast period for 2025-2034. Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the standard and malignant B cells surface. It is indica...
Report ID: 1081 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2025-2034. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). HER2...
Report ID: 1080 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
The nerve growth factor is a tumor tissue produced growth factor that promotes the growth and differentiation of sympathetic and sensory ganglia. It is the first growth factor to be identified. An elevated level of nerve growth factor leads to inflam...
Report ID: 1079 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages:
The Cancer Biosimilars Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031. Biosimilar is defined as a type of biological product that is approved by respective regulatory bodies because of its clinical simil...
Report ID: 1078 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Global Abdominal Aorta Stent Grafts Market is expected to grow at a 4.9% CAGR during the forecast period for 2025-2034. The Aortic abdominal stent graft is used for abdominal aneurysm endovascular repair. Endovascular aneurysm repair (EVAR), is a ne...
Report ID: 1077 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 170
Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through...
Report ID: 1076 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 175
Prevention of progression and proliferation of infectious diseases in the body has always been the point of discussion, which has developed a throng of techniques to alter these effects of the immune system. Immunotherapy is a treatment that uses par...
Report ID: 1074 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 140
Global Bevacizumab Biosimilar Market is expected to grow at an 9.0% CAGR during the forecast period for 2025-2034. Bevacizumab is a recombinant humanized monoclonal antibody that neutralizes vascular endothelial growth factor A (VEGF-A) biologic act...
Report ID: 1073 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 170
TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034. Tumor necrosis factors are a group of cytokines that are secreted by macrophages and may induce cell death of certain tumor cell lines, whic...
Report ID: 1072 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
The Global Clinical Trial Services Market size is valued at USD 22.58 billion in 2023 and is predicted to reach USD 42.86 billion by the year 2031 at an 8.44% CAGR during the forecast period for 2024-2031. The se...
Report ID: 1071 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The Deep Vein Thrombosis Market Size is valued at 958.11 Million in 2022 and is predicted to reach 1343.86 Million by the year 2031 at a 4.0 % CAGR during the forecast period for 2023-2031. Deep vein thrombosis (DVT) is a serious condition that oc...
Report ID: 1070 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
The Breast Cancer Market is expected to grow at an 8.8% CAGR during the forecast period for 2024-2031. Breast cancer start when cells in the breast begin to grow out of control. These cells form tumour that can often see on an x-ray. Breast ca...
Report ID: 1069 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 140
The Etanercept Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an 17.8% CAGR during the forecast period for 2025-2034. Etanercept is a tumor necrosis factor alpha (TNF-&alph...
Report ID: 1068 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
The Ovarian Cancer Market is expected to grow at a 10.5% CAGR during the forecast period for 2024-2031. Ovarian cancer rank fifth in cancer deaths among women and accounting for more deaths than any other cancer of the female reproductive syst...
Report ID: 1067 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The preceding decades have shown higher incidence and prevalence trends for cancer. Globally, the scenario is worsening with the mounting number of cancer patients every year. The number of new cancer cases is predicted to rise by 54% within the next...
Report ID: 1066 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 140
Pharmaceuticals